Lilly plans more investment in two-in-one drugs

Please subscribe to IBJ to decode this article.

tgn;aidsari2neor7oy gegynl&rhs h e en iranalso g 1aetClt prio k sldc Epats eobn le.dd so fu.sir Lbatl# chslw e ek8a:usub e

taend pams motgrdeas ei n nebi aa nnto h hdd ta tpeo iindoa nrwleTnu.neia wkm u spli-y nrvt ancloldsoi uctn inu aeisId lkv dt tcsorlelea moo-Tgilne uemeo esl

i ,itnmdDio noaag iaiaehc T n tthn tei ylL e pth ipasCnoi n imosh lec aeooontng s des n eln itvsndne nia n elvmo f.o .idu uy iytsn n si g c.l etoivittpnWh

h tnld i i tieoet ors ps anea seaed mot ss.i ipfy csl rcigtrDn 1 htosneec nesle analh w - T ev&ayntpan l sctcm ootnil pst ee ee; aor etm e srvieleeeegoithAmeti2efunsht u trao e Nace#t.oivgohrwaaiet fltNen ihm o nhopu adh ri t otogdonitsiustLlete rm terw8yenue og .sip 7sn taili

o tnce rufsrwhil p idesn teestbwplp ee enccde deg e ao oelu ft rtoie efo nurho.iedtLagsyds el s

etrprne socio f - lsonsntknerwoso dtg rL4honoio duey,gog -ndeueo Ternobiel k n0rth-onwmtae nt m eeatv ednieitittifl i sinencle nyo be untIcnphtaelao3Aean0 gitnaw o te ri roon c iapn5gu.tbwi4s uy nl ty l ai orsiiiiS ita e aeiim.nh w sDeton

iu ovg eLo o 2r c dig eltA nv yse1b o ii enagwr tswds a8dent2ilson-he hg ifitetrocmutli&ni nd beee# rspr r e s di2l&wclaysd fs, hssu2s;#ecbroetds tvef#lctid iadr ifeooh;fae mdte dc e1osn eufi y7ao2eiaoaelmup oetlo oeie pkb1o ot&erronw8r.ec;e8nvrci la pr

ne fvismhr eot ,amu ra e nekniscdn m ep ieo ,aantt.hl-iL ibi mrcsetes aiaieehm ts ith awre tyao lgt anp deg tliai aslldc soaeti sted n idrs ld ao alsettey eheio

e yl te vebW;m.lLla isc c21onefycraditcnraa thf ae8esrse 2 pd2 apwoeT sai b enwrdh ea. indieon&oeg tfnei2noeobbr nerToce ods a cticdt2 l& pecol,rts xp ussrcref sohiiep eiv7iohdr1xehn ereeonolps#ifigaw npaeoeois e,t;oiihcy #y eewgeh vi8su# relirraemio s snuietpyeo nodhfnl s0 t ewcte;nle trsi &8 e,tnvius msBorleoel, nh

# ; 0& 6 1

tcrs pt - s xccoststuij bhhsroj/e:i.ulmsow tp/cc owr wprr"n/le ec mstt/